Evidence map›Paper›PMID 40560278›Full record

ArticleClinical oral investigations2025

Evaluation of the antibacterial activity, surface microhardness, and color change of glass ionomer cement containing green synthesized Ag@MoS

Semiha Ekrikaya, Ozcan Karatas, Ebubekir Yilmaz, Nilay Ildiz, Seyma Dadi, Derya Gamze Sahin, Melih Ucar, Ismail Ocsoy

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical oral investigations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Semiha EkrikayaNimet Bayraktar Oral and Dental Health Center, Kayseri, Turkey.
Ozcan KaratasFaculty of Dentistry, Department of Restorative Dentistry, Nuh Naci Yazgan University, Kayseri, Turkey. okaratas@nny.edu.tr.
Ebubekir YilmazFaculty of Dentistry, Department of Restorative Dentistry, Nuh Naci Yazgan University, Kayseri, Turkey.
Nilay IldizMedical Imaging Department, Vocational School of Health Services, Bandirma Onyedi Eylul University, Bandirma, Turkey.
Seyma DadiDepartment of Engineering Fundamental Sciences, Faculty of Engineering and Natural Sciences, Sivas University of Science and Technology, Sivas, Turkey.
Derya Gamze SahinFaculty of Dentistry, Nuh Naci Yazgan University, Kayseri, Turkey.
Melih UcarFaculty of Dentistry, Erciyes University, Kayseri, Turkey.
Ismail OcsoyDepartment of Analytical Chemistry, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of our study is to compare the antibacterial activity, surface microhardness, and color change of glass ionomer cement (GIC) with the addition of green-synthesized silver nanoparticles (Ag NP) and silver molybdenum disulfide (Ag@MoS

methodsOur study consisted of five groups (n = 7): only GIC (control); GIC + Green-synthesized Ag NP; GIC + Green-synthesized Ag@MoS

resultsStatistically significant differences were observed between the experimental and the control groups regarding live bacteria ratio, lactic acid production, inhibition zone, CFUs, and S. mutans metabolic activity (p < 0.05). The highest antibacterial efficacy in the experimental groups was observed in the Ag@MoS

conclusionAdding Ag NP and Ag@MoS

Indexed as

Anti-Bacterial AgentsDisulfidesGlass Ionomer CementsMetal NanoparticlesMolybdenumNanocompositesSilverColorGreen Chemistry TechnologyHardnessMaterials TestingMicrobial Sensitivity TestsStreptococcus mutansSurface PropertiesAnti-Bacterial AgentsDisulfidesGlass Ionomer CementsMolybdenummolybdenum disulfideSilverAg@MoS2 nanocompositeAntibacterial nanoparticlesGlass ionomer cementSurface microhardness

Identifiers

PMID40560278
PMCPMC12198296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.